EPO and cancer: EPO had been reported as a hypoxia-related and immune-associated biomarker in many cancers.[15,16] This protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow.